"Troponin elevation in coronary ischemia and necrosis"

Area of Science:

• Cardiology
• Biomarkers
• Diagnostic Medicine

Background:

• Cardiac troponin (cTn) detection is crucial for diagnosing myocardial infarction (MI).
• Elevated cTn levels are hypothesized to reflect plaque rupture and hypercoagulability, identifying high-risk patients for aggressive treatment.
• High-sensitivity assays offer improved detection rates but may compromise specificity.

Purpose of the Study:

• To evaluate the diagnostic utility and limitations of cardiac troponin assays in myocardial infarction.
• To explore the association between cTn levels, coagulation, platelet reactivity, and plaque rupture.
• To investigate the clinical implications of elevated cTn in various conditions beyond MI.

Main Methods:

• Utilized high-sensitivity troponin assays with the 99th percentile as the positivity threshold.
• Assessed troponin levels at presentation and within 3 to 6 hours for improved diagnostic accuracy.
• Reviewed clinical data and diagnostic criteria for myocardial infarction and other conditions associated with elevated troponin.

Main Results:

• High-sensitivity assays achieve over 90% sensitivity at presentation, with negative predictive values approaching 100% by 3 hours.
• Elevated troponin levels are observed in conditions other than MI, including stroke, pulmonary embolism, sepsis, and heart failure.
• Troponin release has been noted after exercise in athletes and healthy individuals, suggesting non-necrotic origins.

Conclusions:

• While high-sensitivity troponin assays enhance MI detection, their clinical specificity is reduced.
• Elevated troponin levels necessitate careful interpretation considering differential diagnoses.
• Troponin release may originate from cytosolic compartments, not solely from irreversible myocardial damage.